Welcome to the our Aesthetic Medicine news roundup, 17 November 2023.
FDA approves blockbuster Eli Lilly drug for weight loss
The US Food and Drug Administration (FDA) approved Eli Lilly’s blockbuster diabetes drug for weight loss management Wednesday, 08 November, giving patients another tool and opening the door to potentially much wider use.
Published Study Shows PDO Max® Threads Make a Great First Impression for Non-Surgical Rhinoplasty
To change the appearance of their nose, many people have turned to non-surgical rhinoplasty using polydioxanone (PDO) threads. The benefit is a similar result to surgery, without the need for invasive or expensive treatments, or a lengthy recovery period.
Hackers target Las Vegas plastic surgeons, post patient information, naked photos online
The FBI is investigating how cyber criminals obtained medical records and naked patient photos from a Las Vegas plastic surgery office, posting them online for ransom, the 8 News Now Investigators have learned.
FDA to tighten regulation of cosmetic products
Philippines — The Food and Drug Administration (FDA) is set to tighten its regulatory powers over the new breed of cosmetic products with therapeutic claims, as technologies in the skin care industry continue to evolve.
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
CollPlant Biotechnologies today announced that the U.S. Patent and Trademark Office has granted a patent that covers CollPlant’s photocurable dermal filler product candidate, being developed for the aesthetics market.
Primary care doctor’s perception about the scope of plastic surgeons: A national survey.
Plastic surgery is characterized by a broad spectrum of aesthetic and reconstructive surgical expertise that is not defined by an anatomic area. The authors sought to identify primary care doctors’ perceptions of different fields of plastic surgery.
